Apolipoprotein A-I and A-II kinetic parameters as assessed by endogenous labeling with [2H3]leucine in middle-aged and elderly men and women

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 20, Issue 3, 2000, Pages 801-806

  Velez Carrasco, Wanda ^a   Lichtenstein, Alice H ^a   Li, Zhengling ^a   Dolnikowski, Gregory G ^a   Lamon Fava, Stefania ^a   Welty, Francine K ^a   Schaefer, Ernst J ^a  

^a TUFTS UNIVERSITY   (United States)

Author keywords

Apolipoprotein A I; Apolipoprotein A II; Kinetic parameters; Stable isotopes

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LEUCINE; TRIACYLGLYCEROL;

ADULT; AGE; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN EXPERIMENT; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; LIPOPROTEIN SECRETION; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0034016297     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.20.3.801     Document Type: Article

References (37)

1. Gordon DJ, Probstfield JL, Garrison RJ, Neaton MS, Castelli WP, Knoke JD, Jacobs DR, Bangdiwala S, Tyroler A. High-density lipoprotein cholesterol and cardiovascular disease: four prospective American studies. Circulation. 1989;79:8-15.
2. Goldbourt URI, Medalie JH. High density lipoprotein cholesterol and incidence of coronary heart disease: the Israel Ischemic Heart Disease Study. Am J Epidemiol. 1979;109:296-308.
3. Miller NE, Thelle DS, Forde OH, Mjos OD. The Tromso heart-study: high density lipoprotein and coronary heart-disease: a prospective case-control study. Lancet. 1977;1:965-968.
4. Frick MH, Elo O, Haapa K, Heinonen OP, Heinsalmi P, Helo P, Huttanen JK, Kaitaneimi P, Koskinen P, Manninen Y, Maenpaa H, Malkonen M, Manttari M, Norola S, Pasternack A, Pikkarainen J, Romo M, Sjoblom T, Nikkila EA. Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia, N Engl J Med. 1987;317: 1237-1245.
5. Shepherd J, Packard CJ, Patsch JR, Gotto AM Jr. Metabolism of apolipoproteins A-I and A-II and its influence on the high density lipoprotein subtraction distribution in males and females. Eur J Clin Invest. 1978;8: 115-120.
6. Fidge N, Nestel P, Ishikawa T, Reardon M, Billington T. Turnover of apoproteins A-I and A-II of high density lipoprotein and the relationship to other lipoproteins in normal and hyperlipidemic individuals. Metabolism. 1980;29:643-653.
7. Schaefer EJ, Zech LA, Jenkins LL, Bronzert TJ, Rubalcaba EA, Lindgren FT, Aamodt RL, Brewer HB Jr. Human apolipoprotein A-I and A-II metabolism. J Lipid Res. 1982;23:850-862.
8. Gylling H, Vega GL, Grundy SM. Physiologic mechanisms for reduced apolipoprotein A-I concentrations associated with low levels of high density lipoprotein cholesterol in patients with normal plasma lipids. J Lipid Res. 1992;33:1527-1539.
9. Brinton EA, Eisenberg S, Breslow JL. Elevated high density lipoprotein cholesterol levels correlate with decreased apolipoprotein A-I and A-II fractional catabolic rate in women. J Clin Invest. 1989;84:262-269.
10. Brinton EA, Eisenberg S, Breslow JL. Increased apo A-I and apo A-FI fractional catabolic rate in patients with low high density lipoprotein-cholesterol levels with or without hypertriglyceridemia. J Clin Invest. 1991; 87:536-544.
11. 2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. Clin Chem. 1982;28:1379-1388.
12. 2+ precipitation. Clin Chem. 1982;28:1574. Abstract.
13. Havel R, Eder H, Bragdon J. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest. 1955;34:1345-1353.
14. McNamara JR, Schaefer EJ. Automated enzymatic standardized lipid analyses for plasma and lipoprotein fractions. Clin Chim Acta. 1987; 166:1-8.
15. Li Z, McNamara JR, Ordovas JM, Schaefer EJ. Analysis of high density lipoproteins by a modified gradient gel electrophoresis method. J Lipid Res. 1994;35:1698-1711.
16. Li Z, McNamara JR, Fruchart JC, Luc G, Bard JM, Ordovas JM, Wilson PW, Schaefer EJ. Effects of gender and menopausal status on plasma lipoprotein subspecies and particle sizes. J Lipid Res. 1996;37: 1886-1896.
17. Brinton EA, Eisenberg S, Breslow JL. Human HDL cholesterol levels are determined by apoA-I fractional catabolic rate, which correlates inversely with estimates of HDL particle size: effects of gender, hepatic and lipoprotein lipases, triglyceride and insulin levels, and body fat distribution. Arterioscler Thromb. 1994;14:707-720.
18. Contois J, McNamara JR, Lammi-Keefe C, Wilson PWF, Massov T, Schaefer EJ. Reference intervals for plasma apolipoprotein A-I determined with a standardized commercial immunoturbidimetric assay: results from the Framingham Offspring Study Clin Chem. 1996;42: 507-514.
19. Parra HJ, Mezdour H, Ghalim N, Bard JM, Fruchart JC. Differential electroimmunoassay of human LpA-I lipoprotein particles on ready-to-use plates. Clin Chem. 1990;36:1431-1435.
20. Cohn JS, Wagner DA, Cohn SD, Millar JS, Schaefer EJ. Measurement of very low density and low density lipoprotein apolipoprotein (Apo) B-100 and high density lipoprotein Apo A-I production in human subjects using deuterated leucine: effect of fasting and feeding. J Clin Invest. 1990;85: 804-811.
21. Welty FK, Lichtenstein AH, Barrett PH, Dolnikowski GG, Ordovas JM, Schaefer EJ. Production of apolipoprotein B-67 in apolipoprotein B-67/B-100 heterozygotes: technical problems associated with leucine contamination in stable isotope studies. J Lipid Res. 1997;38:1535-1543.
22. Cobelli C, Toffolo G, Bier DM, Nosadini R. Models to interpret kinetic data in stable isotope tracer studies. Am J Physiol. 1987;253: E551-E564.
23. LeCurex LW, Kezdy FJ, Wattenberg BW. The efficiency and kinetics of secretion of apolipoprotein A-I in hepatic and non-hepatic cells. Atherosclerosis. 1994;106:225-233.
24. Lichtenstein AH, Cohn JS, Hachey DL, Millar JS, Ordovas JM, Schaefer EJ. Comparison of deuterated leucine, valine, and lysine in the measurement of human apolipoprotein A-I and B-100 kinetics. J Lipid Res. 1990;31:1693-1701.
25. 3] leucine. J Lipid Res. 1992;33:907-914.
26. Schaefer EJ, Lamon-Fava S, Ordovas JM, Cohn SD, Schaefer MM, Castelli WP, Wilson PWF. Factors associated with low and elevated plasma high density lipoprotein cholesterol and apolipoprotein A-I in the Framingham offspring study. J Lipid Res. 1994;35:871-882.
27. Osborne JC Jr, Schaefer EJ, Powell GM, Lee NS, Zech LA. Molecular properties of radioiodinated apolipoprotein A-I. J Biol Chem. 1984;259: 347-353.
28. Walsh B, Li H, Sacks FM. Effects of postmenopausal hormone replacement with oral and transdermal estrogen on high density lipoprotein metabolism. J Lipid Res. 1994;35:2083-2093.
29. Brinton EA. Oral estrogen replacement therapy in postmenopausal women selectively raises levels and production rates of lipoprotein A-I and lowers hepatic lipase activity without lowering the fractional catabolic rate. Arterioscler Thromb Vasc Biol. 1996;16:431-440.
30. Schaefer EJ, Foster DM, Zech LA, Lindgren FT, Brewer HB Jr, Levy RI. The effects of estrogen administration on plasma lipoprotein metabolism in premenopausal females. J Clin Endocrinol Metab. 1983;57:262-267.
31. Schaefer EJ, Ordovas JM. Metabolism of the apolipoproteins A-I, A-II, and A-IV. In: Segrest J. Albers J, eds. Methods in Enzymology, Plasma Lipoproteins, Part B: Characterization. Cell Biology and Metabolism. New York. NY: Academic Press Inc; 1986:420-442.
32. Le N-A, Ginsberg HN. Heterogeneity of apolipoprotein A-I turnover in subjects with reduced concentrations of plasma high density lipoprotein cholesterol. Metabolism. 1988;37:614-617.
33. Tall AR, Breslow JL. Plasma high-density lipoproteins and atherogenesis. In: Fuster V, Ross R. Topol EJ, eds. Atherosclerosis and Coronary Artery Disease. Philadelphia, Pa: Lippincott-Raven Publishers; 1996:105-128.
34. Blum CB, Levy R, Eisenberg S, Hall M, Goebel R, Herman M. High density lipoprotein metabolism in man. J Clin Invest. 1977;60:795-807.
35. Rader DJ, Castro G, Zech LA, Fruchart JC, Brewer HB Jr. In vivo metabolism of apolipoprotein A-I on high density lipoprotein particles Lp A-I and Lp A-I/A-II. J Lipid Res. 1991;32:1849-1859.
36. Tilly-Kiesi M, Lichtenstein AH, Joven J, Vilella E, Cheung MC, Carrasco WV, Ordovas JM, Dolnikowski G, Schaefer EJ. Impact of gender on the metabolism of apolipoprotein A-I in HDL subclasses Lp A-I and Lp A-I:A-II in older subjects. Arterioscler Thromb Vasc Biol. 1997; 17: 3513-3518.
37. Ikewaki K, Rader DJ, Schaefer JR, Fairwell T, Zech LA, Brewer HB. Evaluation of apo A-I kinetics in humans using simultaneous endogenous stable isotope and exogenous radiotracer methods. J Lipid Res. 1993;34: 2207-2215.